209 related articles for article (PubMed ID: 33008500)
1. Biotech and Breakthroughs in Immuno-Oncology.
Bockman JM
Urol Clin North Am; 2020 Nov; 47(4):511-521. PubMed ID: 33008500
[TBL] [Abstract][Full Text] [Related]
2. Blocking PD-1/PD-L1 in Genitourinary Malignancies: To Immunity and Beyond.
Dallos MC; Drake CG
Cancer J; 2018; 24(1):20-30. PubMed ID: 29360724
[TBL] [Abstract][Full Text] [Related]
3. Targeting the Tumor Microenvironment with Immunotherapy for Genitourinary Malignancies.
Marciscano AE; Madan RA
Curr Treat Options Oncol; 2018 Mar; 19(3):16. PubMed ID: 29520448
[TBL] [Abstract][Full Text] [Related]
4. [Changes in ASP (antigroup-A streptococcal C polysaccharide antibody) and cardiac and renal effects in cases of urogenital cancers during OK-432 immunotherapy, streptococcus preparation].
Tanji S; Koike H; Kumagai K; Fujioka T; Kubo T; Ohhori T; Yoshida I
Nihon Hinyokika Gakkai Zasshi; 1988 Jan; 79(1):49-57. PubMed ID: 3398379
[No Abstract] [Full Text] [Related]
5. [The role of biomarkers in the diagnosis, prognosis and therapy of patients with immuno-oncological treatments of genito-urinary carcinomas].
Compérat E; Eymerit C; Moroch J; Varinot J
Aktuelle Urol; 2018 Apr; 49(2):171-177. PubMed ID: 29587322
[TBL] [Abstract][Full Text] [Related]
6. Combination immunotherapy in genitourinary malignancies.
Hoffman-Censits J; Wilde L
Curr Opin Urol; 2016 Nov; 26(6):523-8. PubMed ID: 27517637
[TBL] [Abstract][Full Text] [Related]
7. [Immunotherapy in uropathology].
Verkarre V; Roussel H; Granier C; Tartour E; Allory Y
Ann Pathol; 2017 Feb; 37(1):90-100. PubMed ID: 28111042
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for genitourinary malignancies in the here and now!
Slovin SF
Urol Oncol; 2016 Apr; 34(4):169-70. PubMed ID: 26705103
[No Abstract] [Full Text] [Related]
9. Big opportunities for small molecules in immuno-oncology.
Adams JL; Smothers J; Srinivasan R; Hoos A
Nat Rev Drug Discov; 2015 Sep; 14(9):603-22. PubMed ID: 26228631
[TBL] [Abstract][Full Text] [Related]
10. Next generation T-cell therapy for genitourinary malignancies, part A: Introduction and current state of the art.
Pantuck M; Palaskas N; Drakaki A
Cancer Treat Res Commun; 2018; 17():8-12. PubMed ID: 30173005
[No Abstract] [Full Text] [Related]
11. Immunotherapy for Metastatic Prostate Cancer: Current and Emerging Treatment Options.
Chakravarty D; Huang L; Kahn M; Tewari AK
Urol Clin North Am; 2020 Nov; 47(4):487-510. PubMed ID: 33008499
[TBL] [Abstract][Full Text] [Related]
12. Immuno-oncology for surgeons.
Lee SL; Al-Shamkhani A; Mirnezami A
Br J Surg; 2019 Sep; 106(10):1273-1282. PubMed ID: 31318438
[TBL] [Abstract][Full Text] [Related]
13. Expression of costimulatory and inhibitory receptors in FoxP3
Toker A; Ohashi PS
Adv Cancer Res; 2019; 144():193-261. PubMed ID: 31349899
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers for immunotherapy in genitourinary malignancies.
Slovin SF
Urol Oncol; 2016 Apr; 34(4):205-13. PubMed ID: 25791754
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in immuno-oncology and its application to urological cancers.
Mataraza JM; Gotwals P
BJU Int; 2016 Oct; 118(4):506-14. PubMed ID: 27123757
[TBL] [Abstract][Full Text] [Related]
16. Novel combination strategies for enhancing efficacy of immune checkpoint inhibitors in the treatment of metastatic solid malignancies.
Flynn MJ; Larkin JMG
Expert Opin Pharmacother; 2017 Oct; 18(14):1477-1490. PubMed ID: 28820000
[TBL] [Abstract][Full Text] [Related]
17. [Immunotherapy for the treatment of patients with genitourinary cancers: Review and perspectives].
Bigot F; Bonnet C; Massard C
Bull Cancer; 2017 Apr; 104(4):370-379. PubMed ID: 28237355
[TBL] [Abstract][Full Text] [Related]
18. Cancer immunotherapy: the art of targeting the tumor immune microenvironment.
da Silva JL; Dos Santos ALS; Nunes NCC; de Moraes Lino da Silva F; Ferreira CGM; de Melo AC
Cancer Chemother Pharmacol; 2019 Aug; 84(2):227-240. PubMed ID: 31240384
[TBL] [Abstract][Full Text] [Related]
19. A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G.
Carosella ED; Ploussard G; LeMaoult J; Desgrandchamps F
Eur Urol; 2015 Aug; 68(2):267-79. PubMed ID: 25824720
[TBL] [Abstract][Full Text] [Related]
20. Immuno-oncology-101: overview of major concepts and translational perspectives.
Allard B; Aspeslagh S; Garaud S; Dupont FA; Solinas C; Kok M; Routy B; Sotiriou C; Stagg J; Buisseret L
Semin Cancer Biol; 2018 Oct; 52(Pt 2):1-11. PubMed ID: 29428479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
